Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global Pharmacovigilance Software Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
Home / Service & Software / Global Pharmacovigilance Software Market

Global Pharmacovigilance Software Market

Comprehensive industry overview, market size, share, trends, and forecast analysis.

Service & Software Jun 2017 Global 350 Pages No of Tables: 220 No of Figures: 60 Reviewed By: Priya M Author: Julie
Request for TOC Speak to Analyst Inquire Before Buying Download Free Sample PDF

Global Pharmacovigilance Software Market

Market Size in USD Billion

CAGR : 17.60%
USD 1.14
2025
USD 4.17
2033
Forecast Period 2025 - 2033
Market Size (Base Year) USD 1.14 Billion
Market Size (Forecast) USD 4.17 Billion
CAGR 17.60%
Major Market Players Data provided in full report

Global Coronavirus pandemic has had a huge impact on the all industries across the globe, Pharmacovigilance Software Market being no exception. As the global economy has hit the rocks, Extent Research has published a report on the global Pharmacovigilance Software market to provide the impacts of the pandemic on the Pharmacovigilance Software market. However, the report also clearly mentions the smart business strategies that can be adopted to sustain on the global platform. The Pharmacovigilance Software market report provides a detailed study of the historical and future trends that are in favor of the market growth. The report also covers vital data including financial figures, market drivers, opportunities, challenges, threats, developmental trends, and strategic planning that will influence the market growth rate over the forecast period.

Data provided by Extent Research. Source: https://www.extentresearch.com/pharmacovigilance-software-market

The research report on global Pharmacovigilance Software market offers the future revenue figures based on the valid and well evaluated historical data. The report covers the significant overview of the global Pharmacovigilance Software market with regard to primary & secondary data and few of the research tools. The market data are presented in the form of bar or pie charts, graphs, tables, and other pictorial representations for gaining holistic knowledge of the Pharmacovigilance Software market. The Pharmacovigilance Software market report also further provides market growth study based on the region distribution which includes regions such as North America, Europe, Asia Pacific, Latin America, Middle East & Africa as the major market attracters. The regional development status will help analyze the demand for the market across various end-use industries located in the different regions.

Amid the COVID-19 pandemic, the Pharmacovigilance Software industry is experiencing a lot of changes in its distribution and production. The key players United BioSource Corporation, Sparta Systems, Oracle Corporation, Ennov Solutions, Max Application, EXTEDO GmbH, AB Cube, Relsys, Online Business Applications, ArisGlobal, have already started complying with the enforced new norms to mitigate the infection. Furthermore, the players are using new solutions and advanced technologies to play a decisive role in influencing the competitiveness of the market players.

Segmentation of the Global Pharmacovigilance Software Market:

By Product type

  • ADR Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated Software,

by Application

  • Pharma & biotech companies, CROs, BPOs, Others,

Report Scope and Market Segmentation

ATTRIBUTES Global Pharmacovigilance Software Market KEY MARKET INSIGHTS
Segments Covered
  • By Product Type: All Products Type Includes
  • By Application: All Application Type Includes
  • By End User: All End User Type Includes
  • By Distribution Channel: All Distribution Channel Includes
Countries Covered
  • North America
    • U.S., Canada, Mexico
  • Europe
    • Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe
  • Asia-Pacific
    • China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific
  • Latin America
    • Brazil, Argentina, Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players
  • Leading Tier 1 Corporations
  • Prominent Regional Manufacturers
  • Emerging Market Disruptors
  • Technology Integrators & Suppliers
  • *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities
  • Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability.
  • Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands.
  • Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities.
  • Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry.
  • Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...
Read more about Julie
Priya M

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...
Learn more about Priya M
BASIC ATTRIBUTES | KEY MARKET INSIGHTS
Report Title Global Pharmacovigilance Software Market
Base Year 2025
Forecast Period 2025 - 2033
Market Size (Base) USD 1.14 Billion
Projected Size USD 4.17 Billion
CAGR 17.60%

Table of Contents

1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pharmacovigilance Software Market Size Growth Rate by Type, 2017 VS 2021 VS 2035 1.2.2 ADR Reporting 1.2.3 Drug Safety Audits 1.2.4 Issue Tracking 1.2.5 Fully Integrated Software 1.3 Market by Application 1.3.1 Global Pharmacovigilance Software Market Size Growth Rate by Application, 2017 VS 2021 VS 2035 1.3.2 Pharma & biotech companies 1.3.3 CROs 1.3.4 BPOs 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pharmacovigilance Software Market Perspective (2017-2035) 2.2 Pharmacovigilance Software Growth Trends by Region 2.2.1 Pharmacovigilance Software Market Size by Region: 2017 VS 2021 VS 2035 2.2.2 Pharmacovigilance Software Historic Market Size by Region (2017-2022) 2.2.3 Pharmacovigilance Software Forecasted Market Size by Region (2023-2035) 2.3 Pharmacovigilance Software Market Dynamics 2.3.1 Pharmacovigilance Software Industry Trends 2.3.2 Pharmacovigilance Software Market Drivers 2.3.3 Pharmacovigilance Software Market Challenges 2.3.4 Pharmacovigilance Software Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pharmacovigilance Software Players by Revenue 3.1.1 Global Top Pharmacovigilance Software Players by Revenue (2017-2022) 3.1.2 Global Pharmacovigilance Software Revenue Market Share by Players (2017-2022) 3.2 Global Pharmacovigilance Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Pharmacovigilance Software Revenue 3.4 Global Pharmacovigilance Software Market Concentration Ratio 3.4.1 Global Pharmacovigilance Software Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Software Revenue in 2021 3.5 Pharmacovigilance Software Key Players Head office and Area Served 3.6 Key Players Pharmacovigilance Software Product Solution and Service 3.7 Date of Enter into Pharmacovigilance Software Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pharmacovigilance Software Breakdown Data by Type 4.1 Global Pharmacovigilance Software Historic Market Size by Type (2017-2022) 4.2 Global Pharmacovigilance Software Forecasted Market Size by Type (2023-2035) 5 Pharmacovigilance Software Breakdown Data by Application 5.1 Global Pharmacovigilance Software Historic Market Size by Application (2017-2022) 5.2 Global Pharmacovigilance Software Forecasted Market Size by Application (2023-2035) 6 North America 6.1 North America Pharmacovigilance Software Market Size (2017-2035) 6.2 North America Pharmacovigilance Software Market Size by Type 6.2.1 North America Pharmacovigilance Software Market Size by Type (2017-2022) 6.2.2 North America Pharmacovigilance Software Market Size by Type (2023-2035) 6.2.3 North America Pharmacovigilance Software Market Share by Type (2017-2035) 6.3 North America Pharmacovigilance Software Market Size by Application 6.3.1 North America Pharmacovigilance Software Market Size by Application (2017-2022) 6.3.2 North America Pharmacovigilance Software Market Size by Application (2023-2035) 6.3.3 North America Pharmacovigilance Software Market Share by Application (2017-2035) 6.4 North America Pharmacovigilance Software Market Size by Country 6.4.1 North America Pharmacovigilance Software Market Size by Country (2017-2022) 6.4.2 North America Pharmacovigilance Software Market Size by Country (2023-2035) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Pharmacovigilance Software Market Size (2017-2035) 7.2 Europe Pharmacovigilance Software Market Size by Type 7.2.1 Europe Pharmacovigilance Software Market Size by Type (2017-2022) 7.2.2 Europe Pharmacovigilance Software Market Size by Type (2023-2035) 7.2.3 Europe Pharmacovigilance Software Market Share by Type (2017-2035) 7.3 Europe Pharmacovigilance Software Market Size by Application 7.3.1 Europe Pharmacovigilance Software Market Size by Application (2017-2022) 7.3.2 Europe Pharmacovigilance Software Market Size by Application (2023-2035) 7.3.3 Europe Pharmacovigilance Software Market Share by Application (2017-2035) 7.4 Europe Pharmacovigilance Software Market Size by Country 7.4.1 Europe Pharmacovigilance Software Market Size by Country (2017-2022) 7.4.2 Europe Pharmacovigilance Software Market Size by Country (2023-2035) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Pharmacovigilance Software Market Size (2017-2035) 8.2 Asia-Pacific Pharmacovigilance Software Market Size by Type 8.2.1 Asia-Pacific Pharmacovigilance Software Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Pharmacovigilance Software Market Size by Type (2023-2035) 8.2.3 Asia-Pacific Pharmacovigilance Software Market Share by Type (2017-2035) 8.3 Asia-Pacific Pharmacovigilance Software Market Size by Application 8.3.1 Asia-Pacific Pharmacovigilance Software Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Pharmacovigilance Software Market Size by Application (2023-2035) 8.3.3 Asia-Pacific Pharmacovigilance Software Market Share by Application (2017-2035) 8.4 Asia-Pacific Pharmacovigilance Software Market Size by Region 8.4.1 Asia-Pacific Pharmacovigilance Software Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Pharmacovigilance Software Market Size by Region (2023-2035) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pharmacovigilance Software Market Size (2017-2035) 9.2 Latin America Pharmacovigilance Software Market Size by Type 9.2.1 Latin America Pharmacovigilance Software Market Size by Type (2017-2022) 9.2.2 Latin America Pharmacovigilance Software Market Size by Type (2023-2035) 9.2.3 Latin America Pharmacovigilance Software Market Share by Type (2017-2035) 9.3 Latin America Pharmacovigilance Software Market Size by Application 9.3.1 Latin America Pharmacovigilance Software Market Size by Application (2017-2022) 9.3.2 Latin America Pharmacovigilance Software Market Size by Application (2023-2035) 9.3.3 Latin America Pharmacovigilance Software Market Share by Application (2017-2035) 9.4 Latin America Pharmacovigilance Software Market Size by Country 9.4.1 Latin America Pharmacovigilance Software Market Size by Country (2017-2022) 9.4.2 Latin America Pharmacovigilance Software Market Size by Country (2023-2035) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pharmacovigilance Software Market Size (2017-2035) 10.2 Middle East & Africa Pharmacovigilance Software Market Size by Type 10.2.1 Middle East & Africa Pharmacovigilance Software Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Pharmacovigilance Software Market Size by Type (2023-2035) 10.2.3 Middle East & Africa Pharmacovigilance Software Market Share by Type (2017-2035) 10.3 Middle East & Africa Pharmacovigilance Software Market Size by Application 10.3.1 Middle East & Africa Pharmacovigilance Software Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Pharmacovigilance Software Market Size by Application (2023-2035) 10.3.3 Middle East & Africa Pharmacovigilance Software Market Share by Application (2017-2035) 10.4 Middle East & Africa Pharmacovigilance Software Market Size by Country 10.4.1 Middle East & Africa Pharmacovigilance Software Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Pharmacovigilance Software Market Size by Country (2023-2035) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 United BioSource Corporation 11.1.1 United BioSource Corporation Company Details 11.1.2 United BioSource Corporation Business Overview 11.1.3 United BioSource Corporation Pharmacovigilance Software Introduction 11.1.4 United BioSource Corporation Revenue in Pharmacovigilance Software Business (2017-2022) 11.1.5 United BioSource Corporation Recent Developments 11.2 Sparta Systems 11.2.1 Sparta Systems Company Details 11.2.2 Sparta Systems Business Overview 11.2.3 Sparta Systems Pharmacovigilance Software Introduction 11.2.4 Sparta Systems Revenue in Pharmacovigilance Software Business (2017-2022) 11.2.5 Sparta Systems Recent Developments 11.3 Oracle Corporation 11.3.1 Oracle Corporation Company Details 11.3.2 Oracle Corporation Business Overview 11.3.3 Oracle Corporation Pharmacovigilance Software Introduction 11.3.4 Oracle Corporation Revenue in Pharmacovigilance Software Business (2017-2022) 11.3.5 Oracle Corporation Recent Developments 11.4 Ennov Solutions 11.4.1 Ennov Solutions Company Details 11.4.2 Ennov Solutions Business Overview 11.4.3 Ennov Solutions Pharmacovigilance Software Introduction 11.4.4 Ennov Solutions Revenue in Pharmacovigilance Software Business (2017-2022) 11.4.5 Ennov Solutions Recent Developments 11.5 Max Application 11.5.1 Max Application Company Details 11.5.2 Max Application Business Overview 11.5.3 Max Application Pharmacovigilance Software Introduction 11.5.4 Max Application Revenue in Pharmacovigilance Software Business (2017-2022) 11.5.5 Max Application Recent Developments 11.6 EXTEDO GmbH 11.6.1 EXTEDO GmbH Company Details 11.6.2 EXTEDO GmbH Business Overview 11.6.3 EXTEDO GmbH Pharmacovigilance Software Introduction 11.6.4 EXTEDO GmbH Revenue in Pharmacovigilance Software Business (2017-2022) 11.6.5 EXTEDO GmbH Recent Developments 11.7 AB Cube 11.7.1 AB Cube Company Details 11.7.2 AB Cube Business Overview 11.7.3 AB Cube Pharmacovigilance Software Introduction 11.7.4 AB Cube Revenue in Pharmacovigilance Software Business (2017-2022) 11.7.5 AB Cube Recent Developments 11.8 Relsys 11.8.1 Relsys Company Details 11.8.2 Relsys Business Overview 11.8.3 Relsys Pharmacovigilance Software Introduction 11.8.4 Relsys Revenue in Pharmacovigilance Software Business (2017-2022) 11.8.5 Relsys Recent Developments 11.9 Online Business Applications 11.9.1 Online Business Applications Company Details 11.9.2 Online Business Applications Business Overview 11.9.3 Online Business Applications Pharmacovigilance Software Introduction 11.9.4 Online Business Applications Revenue in Pharmacovigilance Software Business (2017-2022) 11.9.5 Online Business Applications Recent Developments 11.10 ArisGlobal 11.10.1 ArisGlobal Company Details 11.10.2 ArisGlobal Business Overview 11.10.3 ArisGlobal Pharmacovigilance Software Introduction 11.10.4 ArisGlobal Revenue in Pharmacovigilance Software Business (2017-2022) 11.10.5 ArisGlobal Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst
TESTIMONIALS

What our clients say about us ?

★★★★★

"The standard report was strong from the beginning. What truly added value was the collaboration with the researchers we could openly discuss market insights and request additional data and analyses over several rounds."

Client

Michael Heidecker

Founder and Managing Director

★★★★★

"Extent Research delivered exactly what we needed reliable data, competitive pricing, and outstanding support. Their team was responsive, collaborative, and enhanced the report with custom insights every step of the way."

Client

Dr. Bernd Binder

Product Manager

★★★★★

"Super quick and helpful support even during the holidays! I really appreciated the effort. The report quality was excellent, with clear details and great insights that helped me understand the progress easily. Thank you so much!"

Client

Ryoko Tanaka

Head of Planning Dept

Top Brands That Trust Us

×
Julie
View Profile

Julie

Head of Research & Multidisciplinary Strategist

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly balances analytical rigor with sharp business acumen. Throughout her impressive career, she has evolved from a dedicated research analyst into a visionary leader who specializes in decoding complex market dynamics, analyzing competitive landscapes, and identifying emerging global trends. Her primary mission is to transform raw, intricate data into forward-looking strategies and actionable intelligence that empower stakeholders to make highly informed, strategic decisions.

Data provided by Extent Research. Source: https://www.extentresearch.com/pharmacovigilance-software-market

Under her expert leadership, the team at Extent Research consistently delivers top-tier insights across an incredibly diverse array of international sectors. Whenever she oversees the development of a comprehensive Market Research Report, she ensures that it meticulously covers the specific nuances of the client’s target industry. Her multidisciplinary approach allows her to seamlessly integrate economic indicators and industry intelligence across vast domains. Her remarkable portfolio of sector expertise spans foundational global industries like Agriculture, Chemical & Material, Machinery & Equipment, Automobile & Transportation, Energy & Power, and Aerospace and Defense. Furthermore, she provides critical strategic oversight in fast-paced consumer and tech markets, including Consumer Goods, Food & Beverages, Packaging, Electronics & Semiconductor, Internet & Communication, New Technology, and Service & Software. Her expansive analytical reach also deeply penetrates life sciences and wellness fields, delivering precise data for Medical Care, Medical Devices & Consumables, and Pharma & Healthcare.

Recognized industry-wide for designing highly effective, customized research methodologies, Julie brings a uniquely visionary approach to strategic consulting. She integrates deep data analysis with a macro-economic perspective, ensuring that every piece of industry intelligence is fully utilized to drive meaningful business transformations. Her exceptional ability to work fluidly across so many complex sectors gives her clients a distinct competitive advantage in highly saturated markets. Ultimately, Julie Jayne’s leadership is the driving force behind Extent Research’s unwavering commitment to delivering elite, actionable insights, proving her to be an invaluable asset to organizations looking to navigate the future of global commerce.

Domain Assigned: Multiple Sectors
×
Priya M
View Profile

Priya M

Vice President

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives with highly tailored, research-backed solutions. She brings a wealth of strategic experience to the table, ensuring that decision-makers are armed with the precise intelligence required to navigate highly competitive and rapidly evolving global markets.

Data provided by Extent Research. Source: https://www.extentresearch.com/pharmacovigilance-software-market

Currently serving as a foundational pillar at Extent Research, Priya operates as the primary driving force behind the firm’s unwavering commitment to analytical excellence. She acts as the vital linchpin within the organization’s comprehensive research pipeline, meticulously reviewing and vetting all incoming data and outgoing insights. Her rigorous quality control guarantees that every single Market Research Report published meets elite industry standards for accuracy, relevance, and clarity. Through her steadfast dedication to precision, she ensures that clients receive reliable, transformative intelligence tailored directly to their long-term strategic needs.

Cross-Industry Expertise

Priya’s exceptional analytical prowess is not confined to a single niche. Rather, she possesses a broad, cross-industry expertise that allows her to expertly decode intricate market shifts and uncover hidden economic patterns. Her ability to synthesize complex technological innovations and sector-specific developments allows her to offer fresh, multifaceted perspectives. She expertly oversees data, forecasts, and emerging trends across an expansive spectrum of global industries, including:

  • Aerospace and Defense
  • Agriculture
  • Automobile & Transportation
  • Chemical & Material
  • Consumer Goods
  • Electronics & Semiconductor
  • Energy & Power
  • Food & Beverages
  • Internet & Communication
  • Machinery & Equipment
  • Medical Care
  • Medical Devices & Consumables
  • New Technology
  • Packaging
  • Pharma & Healthcare
  • Service & Software

Transforming Data into Strategy

By analyzing cross-domain developments across these diverse sectors, Priya effortlessly translates highly technical and complex datasets into digestible, actionable intelligence. She does not merely report static facts; she actively brings the intricate world of market intelligence to life, making it highly engaging and educational for investors, seasoned professionals, and corporate leaders alike.

Her exceptional attention to detail and her innate ability to forecast tomorrow’s emerging innovations keep her and her global clientele consistently one step ahead of the curve. Ultimately, Priya M’s unwavering dedication to precision, combined with her forward-thinking methodology, makes her an indispensable asset to the industry. She guarantees that every piece of strategic advice delivered is backed by rigorous, world-class research.

Domain Assigned: Multiple Sectors